Un Jung Kang, MD, is director of translational research at the Marlene and Paolo Fresco Institute of Parkinson’s and Movement Disorders, and co-director of Parekh Center for Interdisciplinary Neurology at NYU Grossman School of Medicine. He was previously chief of Movement Disorders Division at Columbia University, founded by Dr. Stanley Fahn. Dr. Kang received his medical degree from the Johns Hopkins University and completed his neurology residency and movement disorders fellowship training at Columbia University.
His clinical expertise is in movement disorders including Parkinson’s disease. Dr. Kang studies the molecular and cellular mechanisms of brain circuit plasticity underlying both beneficial and detrimental effects of dopaminergic therapy such as dyskinesia using pre-clinical models with cell type-specific modulation and recording, correlated with behaviors. Dr. Kang is also interested in biomarker development in Parkinson’s disease and related disorders. He led the Fox Investigation for New Discovery of Biomarkers (BioFIND) and serves on biospecimen review committees for The Michael J. Fox Foundation’s Parkinson’s Progression Markers Initiative and the National Institutes of Health Parkinson's Disease Biomarker Program.